Director, Research Strategic Collaborations
Revolution Medicines
Summary
Revolution Medicines is seeking a motivated Director, Research Strategic Collaborations to advance Research priorities through external scientific collaborations, coordinated scientific engagement, and effective cross-functional partnerships. Reporting to Senior Director, Research Scientific Liaison and working closely with Research leadership, this individual will evaluate and manage academic collaborations, coordinate collaborative external disclosures, and implement processes that strengthen collaboration execution and portfolio visibility.
Job description
The Opportunity
Revolution Medicines is seeking a motivated Director, Research Strategic Collaborations to advance Research priorities through external scientific collaborations, coordinated scientific engagement, and effective cross-functional partnerships. Reporting to Senior Director, Research Scientific Liaison and working closely with Research leadership, this individual will evaluate and manage academic collaborations, coordinate collaborative external disclosures, and implement processes that strengthen collaboration execution and portfolio visibility.
The ideal candidate combines oncology drug discovery expertise with sound scientific judgment, strong operational capabilities, and excellent relationship-building skills. This role requires the ability to translate complex science into actionable recommendations, influence stakeholders without direct authority, and independently manage multiple scientific workstreams.
Responsibilities
- Support implementation of an external collaboration strategy aligned with corporate, portfolio, and Research priorities.
- Facilitate the identification of potential academic partners offering differentiated expertise, technologies, models, or biological insights.
- Assess the scientific merit, quality, and relevance of collaboration proposals.
- Triage proposals for unique partner capabilities, resource requirements, and potential impact; develop recommendations for leadership review.
- Thought partner with internal scientists and external investigators to define research objectives, deliverables, milestones, and decision points.
- Manage designated collaborations, facilitating scientific discussions, tracking experimental progress, and coordinating issue resolution.
- Coordinate contract execution with Research, Legal, and other stakeholders to support sponsored research agreements, material transfer agreements, NDAs, consulting agreements.
- Conduct periodic collaboration assessments and lead portfolio reviews, informing recommendations to continue, expand, redirect, or conclude partnerships.
- Maintain productive relationships with external investigators and institutional stakeholders, ensuring clear communication and alignment with internal priorities.
- Implement consistent collaboration management practices, including clear responsibilities, review timelines, documentation, and escalation pathways.
- Establish and maintain portfolio dashboards and prepare updates on collaboration progress to support prioritization and resource decisions.
- Identify and implement process improvements that increase efficiency, accountability, and visibility across scientific engagement activities.
- Plan and lead scientific engagements, such as invited speaker seminar series, roundtables, and advisory boards, from planning through execution.
- Maintain a deep understanding of the Research portfolio to anticipate stakeholder needs and support effective coordination.
Required Skills, Experience and Education
- PhD in cancer biology, molecular biology, pharmacology, or a related scientific discipline, with at least 12 years of relevant experience, including at least 8 years in biotechnology or pharmaceuticals.
- Strong foundation in oncology drug discovery and an understanding of how preclinical and translational research informs clinical development.
- Demonstrated experience managing scientific collaborations, research programs, or complex cross-functional initiatives.
- Ability to critically evaluate scientific proposals, identify key data gaps, and develop clear, actionable recommendations.
- Proven ability to build productive relationships and influence scientific experts, cross-functional stakeholders, and external partners without direct authority.
- Excellent scientific writing, presentation, and interpersonal communication skills, with the ability to tailor complex information to diverse audiences.
- Strong organizational skills, attention to detail, and sound judgment, with the ability to independently manage multiple priorities and recognize when leadership input is needed.
- Ability to translate strategic direction into practical plans and deliver results in a dynamic, fast-paced environment.
Preferred Skills
- Experience managing academic collaborations, sponsored research agreements, material transfer agreements, or portfolio planning.
- Familiarity with RAS biology, targeted oncology therapeutics, and translational research.
- Experience developing collaboration assessments, portfolio metrics, dashboards, and operating processes.
- Experience engaging academic investigators and institutional stakeholders within the oncology research community.
Requirements
- PhD in cancer biology, molecular biology, pharmacology, or a related scientific discipline
- At least 12 years of relevant experience
- At least 8 years in biotechnology or pharmaceuticals
- Strong foundation in oncology drug discovery
- Understanding of how preclinical and translational research informs clinical development
- Demonstrated experience managing scientific collaborations, research programs, or complex cross-functional initiatives
- Ability to critically evaluate scientific proposals, identify key data gaps, and develop clear, actionable recommendations
- Proven ability to build productive relationships and influence scientific experts, cross-functional stakeholders, and external partners without direct authority
- Excellent scientific writing, presentation, and interpersonal communication skills
- Strong organizational skills, attention to detail, and sound judgment
- Ability to translate strategic direction into practical plans and deliver results in a dynamic, fast-paced environment
Benefits
- Competitive Cash Compensation
- Equity Awards
- Health Benefits
- Learning & Development Opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.